Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as trabectedin, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying how well trabectedin works in treating patients with
metastatic pancreatic cancer after first-line chemotherapy.